Stay updated on Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-15T03:03:40.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Locations section now lists trial sites across Alabama, Colorado, Florida, Georgia, Michigan, Missouri, Nebraska, New Jersey, Ohio, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, and Virginia. The page shows a new Revision: v3.3.3 tag.
    Difference
    2%
    Check dated 2025-12-24T14:43:07.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2; no visible changes to the Study Details page content in the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T14:15:30.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Removal of the government funding status notice/banner from the page. All study details and content remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-18T07:27:24.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    No significant changes detected between the old and new screenshots; the page content remains the same, including the study title, brief summary, eligibility criteria, and listed locations for NCT03371979. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:25:33.000Z thumbnail image
  8. Check
    109 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and linked details (cc.nih.gov, opm.gov). - Updated version to v3.2.0. - Removed the resource entry for Genetic and Rare Diseases Information Center: Small cell lung carcinoma and the older v3.1.0 version tag.
    Difference
    4%
    Check dated 2025-10-06T06:49:22.000Z thumbnail image

Stay in the know with updates to Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.